• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PXC141200
Medical Device Problem Codes Partial Blockage (1065); Complete Blockage (1094)
Health Effect - Clinical Codes Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
Date of Event 09/20/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Gore® excluder® aaa endoprosthesis - stent graft trunk ipsilateral leg c3 - sn (b)(4).Devices remain implanted and are not available for product evaluation.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
It was reported that the patient presented on (b)(6) 2016 with an abdominal aortic aneurysm that was treated with gore® excluder® aaa endoprostheses.On (b)(6) 2022, the patient presented with complete thrombosis of the contralateral leg endoprosthesis (plc141200) up to the internal bifurcation of the trunk - ipsilateral leg endoprosthesis (rlt231416) and partial thrombosis of the ipsilateral leg of the rlt231416.Additionally, some thrombus formation above the bifurcation of the rlt231416 was noted.A reintervention to reline the ipsilateral leg on the patient's right was planned for (b)(6) 2022.The patient's left will not be treated.
 
Additional Manufacturer Narrative
A review of the manufacturing records indicated the lot met pre-release specifications.On the (b)(6) 2022, the images confirm thrombosis of the left limb from the flow divider of the device to the distal end of the left common iliac.The left external iliac appears to be patent.The right limb has partial thrombosis (the right limb is described in manufacturer reference no.(b)(4), your reference no.(b)(4).There is no thrombosis visible on the (b)(6) 2018 ct.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL SUNNYVALE B/P
1327 orleans drive
sunnyvale CA 94089
Manufacturer Contact
tom hormby
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key15640118
Report Number2953161-2022-01151
Device Sequence Number6444535
Product Code MIH
UDI-Device Identifier00733132609956
UDI-Public00733132609956
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2016
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/16/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date08/17/2019
Device Model NumberPXC141200
Device Catalogue NumberPXC141200
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/23/2022
Supplement Date Received by Manufacturer01/16/2023
Initial Report FDA Received Date10/20/2022
Supplement Report FDA Received Date01/16/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/17/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age71 YR
Patient SexMale
-
-